Literature DB >> 12724420

FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface.

Vladimir N Ivanov1, Pablo Lopez Bergami, Gabriel Maulit, Taka-Aki Sato, David Sassoon, Ze'ev Ronai.   

Abstract

As revealed by intracellular pools of nonactive Fas (Apo-1), export of Fas to the cell surface is often impaired in human tumors, thereby inactivating Fas ligand-mediated apoptosis. Here, we demonstrate that association with Fas-associated phosphatase 1 (FAP-1) attenuates Fas export to the cell surface. Forced expression of FAP-1 reduces cell surface Fas levels and increases the intracellular pool of Fas within the cytoskeleton network. Conversely, expression of dominant-negative forms of FAP-1, or inhibition of FAP-1 expression by short interfering RNA, efficiently up-regulates surface expression of Fas. Inhibition of Fas surface expression by FAP-1 depends on its association with the C terminus of Fas. Mutation within amino acid 275 results in decreased association with FAP-1 and greater export of Fas to the cell surface in melanomas, normal fibroblasts, or Fas null cells. Identifying the role of FAP-1 in binding to, and consequently inhibition of, Fas export to the cell surface provides novel insight into the mechanism underlying the regulation of Fas trafficking, which is commonly impaired in advanced tumors with FAP-1 overexpression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724420      PMCID: PMC164761          DOI: 10.1128/MCB.23.10.3623-3635.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Characterization of the interactions between PDZ domains of the protein-tyrosine phosphatase PTPL1 and the carboxyl-terminal tail of Fas.

Authors:  J Saras; U Engström; L J Góñez; C H Heldin
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

Review 2.  Fas-mediated apoptosis in tumor formation and defense.

Authors:  H Hug
Journal:  Biol Chem       Date:  1997-12       Impact factor: 3.915

3.  Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells.

Authors:  A E Tollefson; T W Hermiston; D L Lichtenstein; C F Colle; R A Tripp; T Dimitrov; K Toth; C E Wells; P C Doherty; W S Wold
Journal:  Nature       Date:  1998-04-16       Impact factor: 49.962

4.  Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.

Authors:  H Ungefroren; M Voss; M Jansen; C Roeder; D Henne-Bruns; B Kremer; H Kalthoff
Journal:  Cancer Res       Date:  1998-04-15       Impact factor: 12.701

5.  Mutations in the Fas antigen in patients with multiple myeloma.

Authors:  T H Landowski; N Qu; I Buyuksal; J S Painter; W S Dalton
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

6.  Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.

Authors:  M Arai; M Kannagi; M Matsuoka; T Sato; N Yamamoto; M Fujii
Journal:  AIDS Res Hum Retroviruses       Date:  1998-02-10       Impact factor: 2.205

7.  Stable suppression of tumorigenicity by virus-mediated RNA interference.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

8.  The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization.

Authors:  A Elsing; H G Burgert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

9.  A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT.

Authors:  E A Atkinson; H Ostergaard; K Kane; M J Pinkoski; A Caputo; M W Olszowy; R C Bleackley
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

10.  Role for tyrosine phosphorylation and Lyn tyrosine kinase in fas receptor-mediated apoptosis in eosinophils.

Authors:  H U Simon; S Yousefi; B Dibbert; H Hebestreit; M Weber; D R Branch; K Blaser; F Levi-Schaffer; G P Anderson
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

View more
  38 in total

1.  The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.

Authors:  Yun-Ju Lai; Victor T G Lin; Ying Zheng; Etty N Benveniste; Fang-Tsyr Lin
Journal:  Mol Cell Biol       Date:  2010-09-27       Impact factor: 4.272

2.  Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism.

Authors:  Dalya Rosner; Victoria Stoneman; Trevor Littlewood; Nicola McCarthy; Nichola Figg; Yinong Wang; George Tellides; Martin Bennett
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  Autophagy chews Fap to promote apoptosis.

Authors:  Sanket Joshi; Kevin M Ryan
Journal:  Nat Cell Biol       Date:  2014-01       Impact factor: 28.824

4.  Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis.

Authors:  Vladimir N Ivanov; Ze'ev Ronai; Tom K Hei
Journal:  J Biol Chem       Date:  2005-11-23       Impact factor: 5.157

5.  miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1.

Authors:  Robert Schickel; Sun-Mi Park; Andrea E Murmann; Marcus E Peter
Journal:  Mol Cell       Date:  2010-06-25       Impact factor: 17.970

6.  The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor β (Tel-PdgfRβ) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp).

Authors:  Weiqi Huang; Liping Hu; Ling Bei; Elizabeth Hjort; Elizabeth A Eklund
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

7.  Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.

Authors:  Alison Bamberg; Elizabeth F Redente; Steve D Groshong; Rubin M Tuder; Carlyne D Cool; Rebecca C Keith; Benjamin L Edelman; Bart P Black; Gregory P Cosgrove; Murry W Wynes; Douglas Curran-Everett; Stijn De Langhe; Luis A Ortiz; Andrew Thorburn; David W H Riches
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

Review 8.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

9.  Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.

Authors:  Wendy A Kimber; Maria Deak; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 10.  Protein tyrosine phosphatases in glioma biology.

Authors:  Anna C Navis; Monique van den Eijnden; Jan T G Schepens; Rob Hooft van Huijsduijnen; Pieter Wesseling; Wiljan J A J Hendriks
Journal:  Acta Neuropathol       Date:  2009-11-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.